| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/18/2008 | CN101199511A Andrographis lactone self-emulsification capsule of antibacterial antiphlogistic |
| 06/18/2008 | CN101199510A Silybin precursor multiphase lipidosome pharmaceutics and preparing method thereof |
| 06/18/2008 | CN101199509A Function of 2',2'-CH3-2'H,4H-3,6'-two benzopyran-4-ketone |
| 06/18/2008 | CN101199508A Salvianic phenol acid or salt phospholipid compound and preparing method thereof |
| 06/18/2008 | CN101199507A Application of furan diene and derivatives in preparing therapeautic cancer medicament |
| 06/18/2008 | CN101199506A Oxaliplatin lyophilized powder injection and preparing method thereof |
| 06/18/2008 | CN101199505A Verapamil liposome and preparing method thereof |
| 06/18/2008 | CN101199504A Function of stilbene oxygen acid or salt in preparing antiatheroscloresis medicament |
| 06/18/2008 | CN101199503A Hif hydroxylase inhibitors |
| 06/18/2008 | CN101199502A Hif hydroxylase inhibitors |
| 06/18/2008 | CN101199501A HIF hydroxylase inhibitors |
| 06/18/2008 | CN101199500A Function of stilbene oxygen acid or salt in preparing antiatheroscloresis medicament |
| 06/18/2008 | CN101199499A Active controlled-release contraceptive emulsion |
| 06/18/2008 | CN101199498A Medicament of anti-nipple tumor virus infection |
| 06/18/2008 | CN101199495A Patch of abstention containing cola stationary medicament and preparing method thereof |
| 06/18/2008 | CN101199494A Kinesia-prevention patch and preparing method thereof |
| 06/18/2008 | CN101199493A Stavudine capsule and preparing method thereof |
| 06/18/2008 | CN101199491A Lamy stationary slice and preparing method thereof |
| 06/18/2008 | CN101199490A Sulphuric acid indene land leather slice and preparing method thereof |
| 06/18/2008 | CN101199489A Double hydrogen arteannuic plain guagui slice and preparing method thereof |
| 06/18/2008 | CN101199488A Hydrochloric acid amantadine amine slice and its preparing method thereof |
| 06/18/2008 | CN101199487A Viramune slice and its preparing method thereof |
| 06/18/2008 | CN101199486A Ratio karoo amine slice and preparing technique thereof |
| 06/18/2008 | CN101199485A Amino-glucose freeze drying-powder pin and its preparing method thereof |
| 06/18/2008 | CN101199480A Compounded propofol fat emulsion injection containing analgesics and process for preparing same |
| 06/18/2008 | CN101199479A Officinal submicro emulsion and process for preparing same |
| 06/18/2008 | CN101199478A Itraconazole freeze-dry emulsion and process for preparing same |
| 06/18/2008 | CN101199477A Ratification of highly purified tranexamic acid injection and quality standard thereof |
| 06/18/2008 | CN101199476A Pennogenyl Saponins percutaneous-absorping preparation |
| 06/18/2008 | CN101199475A Lincomycin hydrochloride sustained-release preparation and process for preparing same |
| 06/18/2008 | CN101199474A Nifuratel gel and process for preparing same |
| 06/18/2008 | CN101199449A Application of hyamine antibiont on dentistry antibacterial replacement material |
| 06/18/2008 | CN101199318A Method for preparing ortho silicic acid, ortho silicic acid as obtained, and its use |
| 06/18/2008 | CN100395276C Catalyzing synthesis of polylactide and polyserine morphodilone from carboxylic acid creatinine guanidine |
| 06/18/2008 | CN100395261C Compound salt of glycyrrhizin and kurarinol, its production and use |
| 06/18/2008 | CN100395260C Organic amine salts of iso-glycyrrhetic acid and their preparing process and use thereof |
| 06/18/2008 | CN100395259C Steroid derivatives |
| 06/18/2008 | CN100395258C Loquat leaf triterpene acid composition and its uses in preparation of medicine against inflammation and antitussive |
| 06/18/2008 | CN100395255C Ammonia maleate rubicin salt, and its preparing method and use |
| 06/18/2008 | CN100395247C Methylnaphthohydroquinone diphosphate sodium tablet and its preparing method |
| 06/18/2008 | CN100395245C Microcrystal |
| 06/18/2008 | CN100395244C Quinolone carboxylic acid derivatives or their salts |
| 06/18/2008 | CN100395242C Naphthalene alkoxy and naphthaquinone kind pyrane carbonic glucoside compound and preparation process thereof |
| 06/18/2008 | CN100395241C Degradeable furan sesterterpenes keratinous spongistatin, and its preparing method and use |
| 06/18/2008 | CN100395237C 2,5-substituted tetrahydroisoquinolines for use as 5-HT6 modulators |
| 06/18/2008 | CN100395236C Piperazine and piperidine derivatives for treatment of neurological diseases |
| 06/18/2008 | CN100395235C Novel crystalline forms of perindopril erbumine. |
| 06/18/2008 | CN100395234C Novel CB1 receptour inverse agonists |
| 06/18/2008 | CN100394983C Doramectin injection fluid containing soyban oil |
| 06/18/2008 | CN100394982C Inflammation-resistant modified imvite and preparing method thereof |
| 06/18/2008 | CN100394977C Turmeric-containing composition |
| 06/18/2008 | CN100394930C Application of cassia seed in preparation of lead-remove promoting drug or health-caring product |
| 06/18/2008 | CN100394929C Ginseng stem leaves general saponin freeze-drying powder injection and its preparation method |
| 06/18/2008 | CN100394924C Application of high permeability medicine composition in preparing pre-nacrosis medicine |
| 06/18/2008 | CN100394923C Application of low molecular citrus pectin in regulation of blood sugar, blood fat and improvement of fatty liver |
| 06/18/2008 | CN100394922C Toxicity-expelling fibrous nutrient and its preparation method |
| 06/18/2008 | CN100394921C Freeze-drying powder for injecting lentinan and its content determination |
| 06/18/2008 | CN100394920C Use of 5-substituted nucleosides for reinforcing the apoptotic effect of cytostatic drugs |
| 06/18/2008 | CN100394919C Medicinal composition for treating vagina disease |
| 06/18/2008 | CN100394918C Preparation of phosphosphingolipid isopropylphenol fatty emulsion and its preparation method |
| 06/18/2008 | CN100394917C Bilobanoate oral-cavity disintegrating tablet and preparation method |
| 06/18/2008 | CN100394916C Method for providing nutraceutical or phytoceutical benefits and inhibiting oxidation using cherry derivatives |
| 06/18/2008 | CN100394915C Use of gingerol oxime in preparing anti-blood platelet aggregation medicine |
| 06/18/2008 | CN100394914C Aarin oral cavity disintegrating tablet and preparation method thereof |
| 06/17/2008 | USRE40387 7,11-dihydroxy 8,8,10,12,16-pentamethyl-3-(1-methyl-2-(2-methyl-4-thiazolyl) ethenyl-17-oxa-4-azabicyclo(14.1.0)heptadecane-5,9-dione and neutralizing buffer in an amount sufficient to reduce its decomposition; increasing the bioavailability of orally administered epothilones; anticarcinogenic agent |
| 06/17/2008 | US7388118 Amine 1,2- and 1,3-diol compounds |
| 06/17/2008 | US7388114 Perfluoropolyether derivative |
| 06/17/2008 | US7388112 Immunomodulation with novel pharmaceutical compositions |
| 06/17/2008 | US7388085 Comprises nucleotide sequences coding polyene macrolide antibiotics for use in veterinary medicine |
| 06/17/2008 | US7388078 Nucleic acids encoding polypeptides having chips activity |
| 06/17/2008 | US7388070 inhibitors of DNA polymerase and DNA repair enzymes for treating viral infections, bacterial infections, fungal infections, protozoan infections, and neoplastic diseases; herpes viruses, herpes simplex virus (HSV), and human cytomegalovirus (CMV); peptidomimetics that mimic helical portions of proteins |
| 06/17/2008 | US7388031 Reacting an epoxy compound with a aminocylcohexane-phenyl derivative; useful as anti-obesity, anti-diabetic, cicatrizing and tocolytic medicinal products |
| 06/17/2008 | US7388030 Suppressors of anemia and appetite suppressors and methods for suppressing anemia and suppressing appetite |
| 06/17/2008 | US7388029 prostaglandin F analogs, such as 13,14-dihydro-15-(2-benzathiozolyl) pentanor Prostaglandin F1 alpha, with other hair growth stimulant; topically to the skin; can arrest hair loss, reverse hair loss, and promote hair growth; cosmetics |
| 06/17/2008 | US7388028 Methoxypolyethylene glycol thioester chelate and uses thereof |
| 06/17/2008 | US7388027 sarcopenia,frailty or age-related functional decline; nonsteroidal, nontoxic; side effect reduction;2-Chloro-4-(7-hydroxy-1-methyl-3-oxo-5,6,7,7a-tetrahydro-3H-pyrrolizin-2-yl)-3-methylbenzonitrile |
| 06/17/2008 | US7388026 Antitumor antibiotic; water solubility, stability; N-[2-{(1-chloromethyl)-1,2-dihydro-5-[(4-methylpiperazino)carbonyloxy]-3H-benz(e)indol-3-yl}carbonyl]-1H-indol-5-yl]-5-[(3-methyldithio-1-oxopropyl)-amino]-1H-indole-2-carboxamide |
| 06/17/2008 | US7388025 3-aryl-isoxazole-4-carbonyl-benzofuran derivatives |
| 06/17/2008 | US7388024 Indeno[2,1A]indenes and isoindolo[2,1-A]indoles |
| 06/17/2008 | US7388023 Amino acids with affinity for the α2δ-protein |
| 06/17/2008 | US7388022 Polysubstituted 1,1-pyridylaminocyclopropanamine compounds |
| 06/17/2008 | US7388021 Novel pyridyl or phenyl ureas and analogues; Purinoreceptors inhibitors; 1-(4-tert-butylphenyl)-3-(2-(3-isopropylphenoxy)pyridin-3-yl)urea; for the treatment of a thromboembolic disorders |
| 06/17/2008 | US7388020 Compounds for chronic obstructive pulminary disorders for breathingand respiratory system diorders |
| 06/17/2008 | US7388019 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 06/17/2008 | US7388018 for controlling phytopathogenic harmful fungi; |
| 06/17/2008 | US7388017 Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease |
| 06/17/2008 | US7388016 10,11-dimethoxydibenzo[c,f]-2,7-naphthyridin-6-amine; inhibiting pyruvate dehydrogenase kinase PDK-1in a cell; antiproliferative agent;brain, colon cancer, leukemia, prostate and breast cancer |
| 06/17/2008 | US7388015 inhibitors of cyclin-dependent kinases (CDKs); cancer, leukemia, psoriasis |
| 06/17/2008 | US7388014 Quinazoline derivatives and therapeutic use thereof |
| 06/17/2008 | US7388013 Capped pyrazinoylguanidine sodium channel blockers |
| 06/17/2008 | US7388012 (Hydrazido)(amino)thiophene compounds |
| 06/17/2008 | US7388011 Inhibiting the proteolytic activity of cathepsin S; 4-{3-[5-Acetyl-3-(4-chloro-phenyl)-4,5,6,7-tetrahydro-pyrazolo[4,3-c]pyridin-1-yl]-2-hydroxy-propyl}-3,4,5,6-tetrahydro-2H-[1,2']bipyrazinyl-3'-carbonitrile; antiarthritic agent; autoimmune disease: lupus, rheumatoid arthritis, and asthma |
| 06/17/2008 | US7388010 fused hexacyclic derivatives consist of pyrrolidine, indazolone, quuinoxalinone rings; cyclin-dependent kinase inhibitor with cell growth-inhibitory activity; anticarcinogenic and antiproliferative agent |
| 06/17/2008 | US7388009 Heterocyclic drugs as enzyme inhibitors for Kinase enzymes or prodrugs |
| 06/17/2008 | US7388008 (1-{5-[(4-amino-benzenesulfonyl)-isobutyl-amino]-6-phosphonooxy-hexacarbomoyl}-2,2-diphenyl-ethyl)-carbamic acid methyl ester; which upon cleavage of cleavable bond or unit generates HIV-1 aspartyl protease inhibitor; antiviral agent; good solubility, and bioavailability; HIV or HTLV infection |
| 06/17/2008 | US7388007 2-(3-acetamido-3-isobutyl-2-oxopyrrolidin-1-yl)-N-(3-(3,5-difluorophenyl)-1-hydroxy-1-(4-propoxypyrrolidin-2-yl)propan-2-yl)-4-phenylbutanamide; beta-amyloid peptide inhibitors; neurodegenerative diseases; Alzheimer's Disease, cerebral amyloid angiopathy and Down's Syndrome |
| 06/17/2008 | US7388006 Non-steroidal progesting |
| 06/17/2008 | US7388005 Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo [1,2-a]pyrimidin-5(1H)one derivatives for neurodegenerative disorders |
| 06/17/2008 | US7388004 4-{4-[3-[3-(4-Fluorophenyl)-3-hydroxypropyl]-2-(4-methoxyphenyl)-4-oxoazetidin-1-yl]benzylamino}butane-1-sulfonic acid; antilipemic, antidiabetic and hypoglycemic agents; insulin resistance |
| 06/17/2008 | US7388003 Δ15-D-Homosteroids with androgenic action |